Document Detail

The "sickle-sign" in bone scintigraphy.
MedLine Citation:
PMID:  7215377     Owner:  NLM     Status:  MEDLINE    
A side-effect of an intensive cytotoxic treatment on bone scanning will be reported: the so called "sickle sign", a diffuse activity around the calvarium seen only in patients at cytotoxic therapy. The differentiation between this harmless side-effect and abnormalities caused by the cancer could be done in our patients by a vertex view. All patients with skull metastases or meningeal carcinosis and this sign in the frontal and lateral view had an inhomogeneous uptake in the vertex view. This view should therefore be added to the standard views in all patients with the sickle sign.
H Creutzig; W Dach
Related Documents :
19890127 - A peptide-based erythropoietin-receptor agonist for pure red-cell aplasia.
11918037 - Preoperative administration of epoetin alfa to total joint arthroplasty patients.
7215377 - The "sickle-sign" in bone scintigraphy.
8577507 - Detection of cerebrovascular disease in patients with sickle cell disease using transcr...
24481227 - The very old on hemodialysis: 8 years' experience in a single unit.
8156947 - Focal electroencephalographic abnormalities in juvenile myoclonic epilepsy.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  European journal of nuclear medicine     Volume:  6     ISSN:  0340-6997     ISO Abbreviation:  Eur J Nucl Med     Publication Date:  1981 Mar 
Date Detail:
Created Date:  1981-06-25     Completed Date:  1981-06-25     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7606882     Medline TA:  Eur J Nucl Med     Country:  GERMANY, WEST    
Other Details:
Languages:  eng     Pagination:  99-101     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antineoplastic Agents / adverse effects
Breast Neoplasms / drug therapy,  radionuclide imaging*
Diagnosis, Differential
Prospective Studies
Skull / radionuclide imaging*
Skull Neoplasms / radionuclide imaging*,  secondary
Reg. No./Substance:
0/Antineoplastic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  On the nature of technetium compounds. 1. A semiquantitative biological model system to assay 99mTc-...
Next Document:  A mathematical model for the liver uptake and excretion of 99mTc-diethyl IDA.